Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07034261
NA
Continuous Glucose Monitoring to Detect Postpartum Dysglycemia in Patients With Gestational Diabetes
Sponsor: University of Chicago
View on ClinicalTrials.gov
Summary
The aim of this study is to determine the ability of postpartum continuous glucose monitoring (CGM) for subjects with gestational diabetes (GDM) to predict dysglycemia on 4-12 week postpartum oral glucose tolerance test (OGTT).
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2026-04
Completion Date
2026-09
Last Updated
2026-02-13
Healthy Volunteers
No
Conditions
Interventions
DEVICE
Blinded Continuous Glucose Monitoring Device
Subjects will be asked to wear blinded continuous glucose monitoring device for 14 days.